Table 1 Baseline characteristics for the study population
All patients (n = 1127) | |
|---|---|
Mean age at inclusion, mean ± SD | 63.6 ± 9.6 |
Females, n (%) | 237 (21.0) |
Low educationa, n (%) | 780 (70.3) |
Family history of coronary heart diseaseb, n (%) | 481 (42.5) |
ST-elevation infarction, n (%) | 335 (29.7) |
Non-ST-elevation infarction, n (%) | 561 (49.8) |
Stable or unstable angina, n (%) | 231 (20.4) |
Percutaneous coronary intervention, n (%) | 867 (77.3) |
Coronary artery bypass graft operation n (%) | 147 (9.6) |
No revascularization, n (%) | 108 (9.6) |
≥ 1 coronary event prior to index event, n (%) | 336 (29.8) |
Heart failure, n (%) | 148 (13.1) |
Atrial fibrillation, n (%) | 106 (9.4) |
Peripheral artery disease, n (%) | 100 (8.9) |
Stroke or transient ischemic attack, n (%) | 80 (7.1) |
Chronic kidney failure (eGFR< 60 mL/min/1.73m2), n (%) | 139 (13.4) |
Participation in cardiac rehabilitation, n (%) | 526 (46.7) |
Former smoking, n (%) | 603 (55.7) |
Current smoking, n (%) | 230 (21.2) |
Total cholesterol, mean ± SD | 4.0 ± 1.0 |
Low density lipoprotein cholesterol, mean ± SD | 2.1 ± 0.8 |
High density lipoprotein cholesterol, mean ± SD | 1.1 ± 0.3 |
Non-high density lipoprotein cholesterol, mean ± SD | 2.9 ± 0.9 |
Low physical activityc, n (%) | 472 (41.9) |
Physical inactivityc n (%) | 197 (18.0) |
Diabetes mellitus, n (%) | 189 (16.9) |
HbA1c in non-diabetic patients, mean ± SD | 5.8 ± 0.5 |
HbA1c in diabetic patients, mean ± SD | 7.6 ± 1.4 |
Systolic blood pressure mmHg, mean ± SD | 138 ± 19.0 |
Diastolic blood pressure mmHg, mean ± SD | 82 ± 8.8 |
Waist circumference cm, mean ± SD | 102.5 ± 12.3 |
Body Mass index in kg/m2, mean ± SD | 28.6 ± 4.5 |
C-reactive protein mg/l, mean ± SD | 2.5 ± 2.7 |
At least 1 antiplatelet agent, n (%) | 1096 (97.2) |
Statin treatment, n (%) | 1036 (91.9) |
Beta-blocker treatment, n (%) | 815 (72.3) |
ACE inhibitor or ARB treatment, n (%) | 561 (49.8) |
HADS Anxiety sum score, mean ± SD | 4.8 ± 3.2 |
HADS Depression sum score, mean ± SD | 3.9 ± 3.2 |